Immunoevasive aspergillus virulence factors

Mycopathologia

Volumn 178, Issue 5-6, 2014, Pages 363-370

  Chotirmall, Sanjay H ^a,b   Mirkovic, Bojana ^a   Lavelle, Gillian M ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Aspergillus; Factors; Immune; Infection; Virulence

Indexed keywords

ASPERGILLUS;

VIRULENCE FACTOR;

ASPERGILLOSIS; ASPERGILLUS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ASPERGILLOSIS; ASPERGILLUS; HUMANS; IMMUNE EVASION; VIRULENCE FACTORS;

EID: 84912061607     PISSN: 0301486X     EISSN: 15730832     Source Type: Journal    
DOI: 10.1007/s11046-014-9768-y     Document Type: Article

References (44)

1. Cramer RA, Rivera A, Hohl TM. Immune responses against Aspergillus fumigatus: what have we learned? Curr Opin Infect Dis. 2011;24(4):315–22. doi:10.1097/QCO.0b013e328348b159.
2. Osherov N. Interaction of the pathogenic mold Aspergillus fumigatus with lung epithelial cells. Front Microbiol. 2012;3:346. doi:10.3389/fmicb.2012.00346.
3. Chotirmall SH, Al-Alawi M, Mirkovic B, Lavelle G, Logan PM, Greene CM, et al. Aspergillus-associated airway disease, inflammation, and the innate immune response. Biomed Res Int. 2013;2013:723129. doi:10.1155/2013/723129.
4. Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus—what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 2013;9(12):e1003743. doi:10.1371/journal.ppat.1003743.
5. Daly P, Kavanagh K. Pulmonary aspergillosis: clinical presentation, diagnosis and therapy. Br J Biomed Sci. 2001;58(3):197–205.
6. Antachopoulos C, Roilides E. Cytokines and fungal infections. Br J Haematol. 2005;129(5):583–96. doi:10.1111/j.1365-2141.2005.05498.x.
7. Murdock BJ, Shreiner AB, McDonald RA, Osterholzer JJ, White ES, Toews GB, et al. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary exposure to Aspergillus fumigatus conidia. Infect Immun. 2011;79(1):125–35. doi:10.1128/IAI.00508-10.
8. Murdock BJ, Falkowski NR, Shreiner AB, Sadighi Akha AA, McDonald RA, White ES, et al. Interleukin-17 drives pulmonary eosinophilia following repeated exposure to Aspergillus fumigatus conidia. Infect Immun. 2012;80(4):1424–36. doi:10.1128/IAI.05529-11.
9. Gresnigt MS, Rosler B, Jacobs CW, Becker KL, Joosten LA, van der Meer JW, et al. The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses. Eur J Immunol. 2013;43(2):416–26. doi:10.1002/eji.201242711.
10. Cunha C, Aversa F, Lacerda JF, Busca A, Kurzai O, Grube M, et al. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. N Engl J Med. 2014;370(5):421–32. doi:10.1056/NEJMoa1211161.
11. Gresnigt MS, Bozza S, Becker KL, Joosten LA, Abdollahi-Roodsaz S, van der Berg WB, et al. A polysaccharide virulence factor from Aspergillus fumigatus elicits anti-inflammatory effects through induction of interleukin-1 receptor antagonist. PLoS Pathog. 2014;10(3):e1003936. doi:10.1371/journal.ppat.1003936.
12. Bergmann A, Hartmann T, Cairns T, Bignell EM, Krappmann S. A regulator of Aspergillus fumigatus extracellular proteolytic activity is dispensable for virulence. Infect Immun. 2009;77(9):4041–50. doi:10.1128/IAI.00425-09.
13. Dagenais TR, Keller NP. Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev. 2009;22(3):447–65. doi:10.1128/CMR.00055-0822/3/447.
14. Rementeria A, Lopez-Molina N, Ludwig A, Vivanco AB, Bikandi J, Ponton J, et al. Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol. 2005;22(1):1–23.
15. Kurup VP, Shen HD, Banerjee B. Respiratory fungal allergy. Microbes Infect. 2000;2(9):1101–10.
16. Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru SR, et al. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature. 2009;460(7259):1117–21. doi:10.1038/nature08264.
17. Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry C, et al. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol. 2007;9(6):1588–600. doi:10.1111/j.1462-5822.2007.00895.x.
18. Paris S, Debeaupuis JP, Crameri R, Carey M, Charles F, Prevost MC, et al. Conidial hydrophobins of Aspergillus fumigatus. Appl Environ Microbiol. 2003;69(3):1581–8. doi:10.1128/aem.69.3.1581-1588.2003.
19. Thau N, Monod M, Crestani B, Rolland C, Tronchin G, Latgé JP, et al. Rodletless mutants of Aspergillus fumigatus. Infect Immun. 1994;62(10):4380–8.
20. Abad A, Fernandez-Molina JV, Bikandi J, Ramirez A, Margareto J, Sendino J, et al. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol. 2010;27(4):155–82. doi:10.1016/j.riam.2010.10.003.
21. Chai LY, Netea MG, Sugui J, Vonk AG, van de Sande WW, Warris A, et al. Aspergillus fumigatus conidial melanin modulates host cytokine response. Immunobiology. 2010;215(11):915–20. doi:10.1016/j.imbio.2009.10.002.
22. Jahn B, Koch A, Schmidt A, Wanner G, Gehringer H, Bhakdi S, et al. Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun. 1997;65(12):5110–7.
23. Thywissen A, Heinekamp T, Dahse HM, Schmaler-Ripcke J, Nietzsche S, Zipfel PF, et al. Conidial dihydroxynaphthalene melanin of the human pathogenic fungus Aspergillus fumigatus interferes with the host endocytosis pathway. Front Microbiol. 2011;2:96. doi:10.3389/fmicb.2011.00096.
24. Volling K, Thywissen A, Brakhage AA, Saluz HP. Phagocytosis of melanized Aspergillus conidia by macrophages exerts cytoprotective effects by sustained PI3 K/Akt signalling. Cell Microbiol. 2011;13(8):1130–48. doi:10.1111/j.1462-5822.2011.01605.x.
25. Paris S, Wysong D, Debeaupuis JP, Shibuya K, Philippe B, Diamond RD, et al. Catalases of Aspergillus fumigatus. Infect Immun. 2003;71(6):3551–62. doi:10.1128/iai.71.6.3551-3562.2003.
26. Calera JA, Paris S, Monod M, Hamilton AJ, Debeaupuis JP, Diaquin M, et al. Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus. Infect Immun. 1997;65(11):4718–24.
27. Scharf DH, Heinekamp T, Remme N, Hortschansky P, Brakhage AA, Hertweck C. Biosynthesis and function of gliotoxin in Aspergillus fumigatus. Appl Microbiol Biotechnol. 2012;93(2):467–72. doi:10.1007/s00253-011-3689-1.
28. Kupfahl C, Michalka A, Lass-Florl C, Fischer G, Haase G, Ruppert T, et al. Gliotoxin production by clinical and environmental Aspergillus fumigatus strains. Int J Med Microbiol. 2008;298(3–4):319–27. doi:10.1016/j.ijmm.2007.04.006.
29. Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol. 2010;150(4):406–17. doi:10.1111/j.1365-2141.2010.08283.xBJH8283.
30. Spikes S, Xu R, Nguyen CK, Chamilos G, Kontoyiannis DP, Jacobson RH, et al. Gliotoxin production in Aspergillus fumigatus contributes to host-specific differences in virulence. J Infect Dis. 2008;197(3):479–86. doi:10.1086/525044.
31. Chotirmall SH, McElvaney NG. Fungi in the cystic fibrosis lung: bystanders or pathogens? Int J Biochem Cell Biol. 2014;. doi:10.1016/j.biocel.2014.03.001.
32. Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, Louden L, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27(1):158–63.
33. Bargon J, Dauletbaev N, Kohler B, Wolf M, Posselt HG, Wagner TO. Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients. Respir Med. 1999;93(11):835–8.
34. Jubin V, Ranque S. Stremler Le Bel N, Sarles J, Dubus JC. Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Pediatr Pulmonol. 2010;45(8):764–71. doi:10.1002/ppul.21240.
35. de Vrankrijker AM, van der Ent CK, van Berkhout FT, Stellato RK, Willems RJ, Bonten MJ, et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect. 2011;17(9):1381–6. doi:10.1111/j.1469-0691.2010.03429.x.
36. McMahon MA, Chotirmall SH, McCullagh B, Branagan P, McElvaney NG, Logan PM. Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population. Eur J Radiol. 2012;81(3):e197–202. doi:10.1016/j.ejrad.2011.01.114.
37. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest. 2010;137(1):171–6. doi:10.1378/chest.09-1103.
38. Coughlan CA, Chotirmall SH, Renwick J, Hassan T, Low TB, Bergsson G, et al. The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis. Am J Respir Crit Care Med. 2012;186(10):999–1007. doi:10.1164/rccm.201203-0478OC.
39. Kreindler JL, Steele C, Nguyen N, Chan YR, Pilewski JM, Alcorn JF, et al. Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest. 2010;120(9):3242–54. doi:10.1172/JCI42388.
40. Wittke A, Weaver V, Mahon BD, August A, Cantorna MT. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol. 2004;173(5):3432–6.
41. Nguyen NL, Chen K, McAleer J, Kolls JK. Vitamin D regulation of OX40 ligand in immune responses to Aspergillus fumigatus. Infect Immun. 2013;81(5):1510–9. doi:10.1128/IAI.01345-12.
42. Burgel PR, Baixench MT, Amsellem M, Audureau E, Chapron J, Kanaan R, et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob Agents Chemother. 2012;56(2):869–74. doi:10.1128/AAC.05077-11.
43. Baxter CG, Dunn G, Jones AM, Webb K, Gore R, Richardson MD, et al. Novel immunologic classification of aspergillosis in adult cystic fibrosis. J Allergy Clin Immunol. 2013;132(3):560–6e10. doi:10.1016/j.jaci.2013.04.007.
44. Wartenberg D, Lapp K, Jacobsen ID, Dahse HM, Kniemeyer O, Heinekamp T, et al. Secretome analysis of Aspergillus fumigatus reveals Asp-hemolysin as a major secreted protein. Int J Med Microbiol. 2011;301(7):602–11. doi:10.1016/j.ijmm.2011.04.016.